Literature DB >> 12712342

Tumor stage and early mortality for surgical resections in lung cancer.

Erich Stoelben1, Willi Sauerbrei, Corinna Ludwig, Joachim Hasse.   

Abstract

BACKGROUND: Postoperative mortality rates have been published in relation to operative procedure or preexisting pulmonary and extrapulmonary diseases. We analyzed our patients for the effect of the postoperative tumor stage on perioperative mortality. PATIENTS AND METHODS: Retrospective study of all thoracotomies for resections ( n=1281) in primary lung cancer from January 1987 to December 1997. Uni- and multivariate analysis was performed for operative procedure, mortality (30 and 90 days), tumor stage, sex, age, tumor localization, and completeness of resection. Radical resection was achieved in 91.9% of the patients.
RESULTS: Overall postoperative deaths occurred in 4% and 7.3% of patients after 30 and 90 days respectively. Depending on the operative procedure the mortality after segmental resection ( n=116) was 0.9% and 1.7%, lobectomy ( n=621) 3.0% and 5.7%, sleeve lobectomy ( n=152) 5.3% and 7.9%, and pneumonectomy ( n=314) 6.7% and 12.5%, respectively. Within 30 and 90 days postoperatively deaths occurred, respectively, in 0.8% and 1.0% of stage I patients ( n=493), 5.4% and 5.4% of stage II ( n=147), 4.9% and 8.8% of stage IIIa ( n=388), 7.2% and 16.6% of stage IIIb ( n=148), 8.9% and 20.5% and of stage IV ( n=114). Multivariate analysis showed postoperative tumor stage to be the factor most closely related to within the first 90 days.
CONCLUSIONS: Tumor stage but not type of resection is the strongest predictor of postoperative mortality in these subpopulations.

Entities:  

Mesh:

Year:  2003        PMID: 12712342     DOI: 10.1007/s00423-003-0354-x

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  17 in total

1.  Age does not influence early and late tumor-related outcome after surgery for bronchogenic carcinoma.

Authors:  P Goldstraw
Journal:  Ann Thorac Surg       Date:  2000-03       Impact factor: 4.330

2.  Age and the treatment of lung cancer.

Authors:  J S Brown; D Eraut; C Trask; A G Davison
Journal:  Thorax       Date:  1996-06       Impact factor: 9.139

3.  [Mortality rate after lung resection for bronchial carcinoma (author's transl)].

Authors:  H Stanulla; J Wilde
Journal:  Zentralbl Chir       Date:  1977       Impact factor: 0.942

4.  Resection rates and postoperative mortality in 7,899 patients with lung cancer.

Authors:  R A Damhuis; P R Schütte
Journal:  Eur Respir J       Date:  1996-01       Impact factor: 16.671

5.  Thirty-day operative mortality for thoracotomy in lung cancer.

Authors:  H Wada; T Nakamura; K Nakamoto; M Maeda; Y Watanabe
Journal:  J Thorac Cardiovasc Surg       Date:  1998-01       Impact factor: 5.209

6.  Four decades of experience with resections for bronchogenic carcinoma at the Massachusetts General Hospital.

Authors:  E W Wilkins; J G Scannell; J G Craver
Journal:  J Thorac Cardiovasc Surg       Date:  1978-09       Impact factor: 5.209

7.  Complications of surgery in the treatment of carcinoma of the lung.

Authors:  F Nagasaki; B J Flehinger; N Martini
Journal:  Chest       Date:  1982-07       Impact factor: 9.410

8.  Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA.

Authors:  M T van Rens; A B de la Rivière; H R Elbers; J M van Den Bosch
Journal:  Chest       Date:  2000-02       Impact factor: 9.410

Review 9.  Age does not influence early and late tumor-related outcome for bronchogenic carcinoma.

Authors:  F Bernet; R Brodbeck; M O Guenin; G Schüpfer; J M Habicht; P M Stulz; T P Carrel
Journal:  Ann Thorac Surg       Date:  2000-03       Impact factor: 4.330

10.  Age trends of lung cancer stage at diagnosis. Implications for lung cancer screening in the elderly.

Authors:  M A O'Rourke; J R Feussner; P Feigl; J Laszlo
Journal:  JAMA       Date:  1987-08-21       Impact factor: 56.272

View more
  4 in total

1.  Comparison of surgical outcomes after pneumonectomy and pulmonary function-preserving surgery for non-small cell lung cancer.

Authors:  Mitsunori Higuchi; Hironori Takagi; Yuki Ozaki; Takuya Inoue; Yuzuru Watanabe; Takumi Yamaura; Mitsuro Fukuhara; Satoshi Muto; Naoyuki Okabe; Yuki Matsumura; Takeo Hasegawa; Jun Osugi; Mika Hoshino; Yutaka Shio; Hiroyuki Suzuki
Journal:  Fukushima J Med Sci       Date:  2018-02-20

2.  Sleeve lobectomy compared with pneumonectomy for operable centrally located non-small cell lung cancer: a meta-analysis.

Authors:  Zhengjun Li; Wei Chen; Mozhu Xia; Hongxu Liu; Yongyu Liu; Ilhan Inci; Fabio Davoli; Ryuichi Waseda; Pier Luigi Filosso; Abby White
Journal:  Transl Lung Cancer Res       Date:  2019-12

3.  Pneumonectomy - permanent injury or still effective method of treatment? Early and long-term results and quality of life after pneumonectomy due to non-small cell lung cancer.

Authors:  Piotr J Skrzypczak; Magdalena Roszak; Mariusz Kasprzyk; Anna Kopczyńska; Piotr Gabryel; Wojciech Dyszkiewicz
Journal:  Kardiochir Torakochirurgia Pol       Date:  2019-04-04

Review 4.  Updated Prognostic Factors in Localized NSCLC.

Authors:  Simon Garinet; Pascal Wang; Audrey Mansuet-Lupo; Ludovic Fournel; Marie Wislez; Hélène Blons
Journal:  Cancers (Basel)       Date:  2022-03-09       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.